IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,095 | $46,106 | $34,115 | $56,101 |
| - Cash | $288 | $454 | $113 | $144 |
| + Debt | $987 | $1,067 | $1,470 | $1,031 |
| Enterprise Value | $34,794 | $46,719 | $35,472 | $56,987 |
| Revenue | $3,898 | $3,661 | $3,367 | $3,215 |
| % Growth | 6.5% | 8.7% | 4.7% | – |
| Gross Profit | $2,379 | $2,190 | $2,004 | $1,889 |
| % Margin | 61% | 59.8% | 59.5% | 58.8% |
| EBITDA | $1,276 | $1,218 | $1,015 | $1,040 |
| % Margin | 32.7% | 33.3% | 30.1% | 32.3% |
| Net Income | $888 | $845 | $679 | $745 |
| % Margin | 22.8% | 23.1% | 20.2% | 23.2% |
| EPS Diluted | 10.67 | 10.06 | 8.03 | 8.6 |
| % Growth | 6.1% | 25.3% | -6.6% | – |
| Operating Cash Flow | $929 | $907 | $543 | $756 |
| Capital Expenditures | -$131 | -$134 | -$149 | -$120 |
| Free Cash Flow | $798 | $773 | $394 | $636 |